Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference

      Lupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference

      Medical Dialogues Bureau11 March 2020 4:11 PM IST
      Mumbai: Lupin Limited won the coveted India Pharma Leader Award at the India Pharma 2020 and India Medical Device 2020 conference. This was...
      Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crores

      Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crores

      Medical Dialogues Bureau11 March 2020 3:30 PM IST
      New Delhi: Torrent Pharmaceuticals has said it has received shareholders'' nod to raise up to Rs 5,000 crore through various instruments, including...
      Pharmacist at Punes reputed hospital arrested for stealing masks

      Pharmacist at Pune's reputed hospital arrested for stealing masks

      Medical Dialogues Bureau11 March 2020 1:23 PM IST
      The 28-year-old accused stole masks, injections, tablets and some ointments, collectively worth Rs 35,750, from the hospital pharmacy where he was...
      USFDA completes inspection of Natcos Kothur formulation facility

      USFDA completes inspection of Natco's Kothur formulation facility

      Medical Dialogues Bureau11 March 2020 1:07 PM IST
      Hyderabad: Natco Pharma Limited has announced the completion of a Pre-approval inspection from the United States Food and Drug Administration (USFDA)...
      Coronavirus: 5 medical stores license cancelled for selling masks, sanitisers at inflated rates

      Coronavirus: 5 medical stores license cancelled for selling masks, sanitisers at inflated rates

      Medical Dialogues Bureau11 March 2020 12:28 PM IST
      Raids were conducted under the aegis of additional city magistrate (ACM) upon the instruction of the district magistrate (DM).
      FDA, FTC Warn Seven Companies Selling Fraudulent Products to Treat COVID-19

      FDA, FTC Warn Seven Companies Selling Fraudulent Products to Treat COVID-19

      Medical Dialogues Bureau11 March 2020 11:00 AM IST
      The FDA and FTC jointly issued warning letters to Vital Silver, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, GuruNanda,...
      Zydus, XOMA enter into licensing agreement for  IL-2-Based Immuno-Oncology Therapy

      Zydus, XOMA enter into licensing agreement for IL-2-Based Immuno-Oncology Therapy

      Medical Dialogues Bureau11 March 2020 9:00 AM IST
      Ahmedabad, Emeryville: Zydus Cadila and XOMA Corporation have announced they have entered into a licensing agreement to advance an IL-2-based...
      USFDA Accepts Biocon, Mylans application for review of   Proposed Biosimilar of Bevacizumab

      USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab

      Medical Dialogues Bureau10 March 2020 1:15 PM IST
      Biocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
      AstraZeneca fails to meet target endpoints in Phase II bladder cancer trial

      AstraZeneca fails to meet target endpoints in Phase II bladder cancer trial

      Medical Dialogues Bureau10 March 2020 9:30 AM IST
      USA: The Phase III DANUBE trial for Imfinzi (durvalumab) and Imfinzi plus tremelimumab in unresectable, Stage IV (metastatic) bladder cancer did not...
      Biogen, Sangamo collaborate for gene regulation therapies in neurological ailments

      Biogen, Sangamo collaborate for gene regulation therapies in neurological ailments

      Medical Dialogues Bureau10 March 2020 9:00 AM IST
      Biogen has exclusive global rights to ST-501 for tauopathies including Alzheimer's disease, ST-502 for synucleinopathies including Parkinson's...
      NPPA gives a deadline to manufacturers to submit availability data of 58 APIs

      NPPA gives a deadline to manufacturers to submit availability data of 58 APIs

      Medical Dialogues Bureau9 March 2020 1:48 PM IST
      New Delhi: Following with earlier order where the apex drug price regulator, National Pharmaceutical Pricing Authority (NPPA) had asked...
      Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder

      Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder

      Medical Dialogues Bureau9 March 2020 12:26 PM IST
      IRVINE -Urovant Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok